Search results
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 6 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Rep. Sheila Jackson Lee reveals she's been diagnosed with pancreatic cancer. Here's what to know...
Yahoo Life· 2 days agoWhy pancreatic cancer is so deadly The subtlety of pancreatic cancer’s symptoms is one of the...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 4 days ago“This is in contrast to many clinical trials in small cell lung cancer where the benefit may only be...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 3 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 10 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Cancer Survivors Are Sharing The Weird Symptom That Made Them Go "Hm, Something Isn't Right Here,"...
BuzzFeed via Yahoo News· 5 days ago"If they tell you it might be cancer and have you come back in a couple of weeks for a biopsy, say...
The Biggest Risk Factor for Bladder Cancer Has Nothing to Do With Pee, Diet, or Genes
Verywell Health via Yahoo News· 1 day agoBladder cancer is common, but one of the biggest risk factors is something you can quit—cigarettes....
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 4 days agoIn 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieved
‘Bald Ballerina’ with Stage 4 cancer inspires new generation of dancers
The Baltimore Banner· 6 days ago“Play Disney classics!” one student shouted in response to the dance instructor’s question about...
...Ifebemtinib in Combination with Garsorasib in Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C...
WKBN 27 Youngstown· 7 days ago...of therapeutic modalities NANJING, China, May 30, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against tumor-treatment resistance and metastasis, today announced results from the Phase Ib/II...) inhibitor, in combination with...